Edge Therapeutics - 48 Year Dividend History | PDSB

Historical dividend payout and yield for Edge Therapeutics (PDSB) since 1971. The current TTM dividend payout for Edge Therapeutics (PDSB) as of December 13, 2019 is $0.00. The current dividend yield for Edge Therapeutics as of December 13, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.016B $0.000B
PDS Biotechnology Corp. is an immuno-oncology company. It is focused on developing a pipeline of clinical-stage immunotherapies to treat cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, cancer and other cancers. The company's products are based on the proprietary Versamune(R) platform technology, which activates and directs the human immune system. PDS Biotechnology Corp, formerly known as Edge Therapeutics Inc., is based in Berkeley Heights, United States.
Stock Name Country Market Cap PE Ratio